Rationale and Application of PEGylated Lipid-Based System for Advanced Target Delivery of siRNA
RNA interference (RNAi) technology has become a powerful tool in application of unraveling the mechanism of disease and may hold the potential to be developed for clinical uses. Small interfering RNA (siRNA) can bind to target mRNA with high specificity and efficacy and thus inhibit the expression o...
Main Authors: | Xuemei Ge, Lijuan Chen, Bo Zhao, Weien Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.598175/full |
Similar Items
-
Advances in Lipid Nanoparticles for siRNA Delivery
by: Sam Chen, et al.
Published: (2013-09-01) -
Lipid nanoparticles for targeted siRNA delivery – going from bench to bedside
by: Zatsepin TS, et al.
Published: (2016-07-01) -
Dendrimers for siRNA Delivery
by: Swati Biswas, et al.
Published: (2013-02-01) -
Novel PEGylated Lipid Nanoparticles Have a High Encapsulation Efficiency and Effectively Deliver MRTF-B siRNA in Conjunctival Fibroblasts
by: Amisha Sanghani, et al.
Published: (2021-03-01) -
Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery
by: Wanyi Tai
Published: (2019-06-01)